Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer’s disease

Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene

(2017) Jon Valla et al.   JOURNAL OF ALZHEIMERS DISEASE

A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease

(2017) Sofia Tzimopoulou et al.   JOURNAL OF ALZHEIMERS DISEASE

Summary Metrics to Assess Alzheimer Disease-Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison

(2012) A. Caroli et al.   JOURNAL OF NUCLEAR MEDICINE

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

(2011) Suzanne Craft   ARCHIVES OF NEUROLOGY

Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay

(2011) Stefan Förster et al.   BIOLOGICAL PSYCHIATRY

Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment

(2011) K. Herholz et al.   JOURNAL OF NUCLEAR MEDICINE

Functional connectivity tracks clinical deterioration in Alzheimer's disease

(2011) Jessica S. Damoiseaux et al.   NEUROBIOLOGY OF AGING

Characterizing Alzheimer's disease using a hypometabolic convergence index

(2011) Kewei Chen et al.   NEUROIMAGE

Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

(2011) Y. Chen et al.   NEUROLOGY

New Computer-Aided Diagnosis of Dementia Using Positron Emission Tomography: Brain Regional Sensitivity-Mapping Method

(2011) Akihiro Kakimoto et al.   PLoS One

Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease

(2010) K.B. Walhovd et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes

(2010) Laura D. Baker et al.   ARCHIVES OF NEUROLOGY

Integrating ADNI results into Alzheimer's disease drug development programs

(2010) Jeffrey L. Cummings   NEUROBIOLOGY OF AGING

Report of the task force on designing clinical trials in early (predementia) AD

(2010) P. S. Aisen et al.   NEUROLOGY

Comparing predictors of conversion and decline in mild cognitive impairment

(2010) S. M. Landau et al.   NEUROLOGY

Relative Capability of MR Imaging and FDG PET to Depict Changes Associated with Prodromal and Early Alzheimer Disease

(2010) David S. Karow et al.   RADIOLOGY

Comparison of Eight Methods for the Estimation of the Image-Derived Input Function in Dynamic [18F]-FDG PET Human Brain Studies

(2009) Paolo Zanotti-Fregonara et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

(2009) Susan M. Landau et al.   NEUROBIOLOGY OF AGING

Cognitive and Cerebral Metabolic Effects of Celecoxib Versus Placebo in People With Age-Related Memory Loss: Randomized Controlled Study

(2008) Gary W. Small et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

False discovery rate revisited: FDR and topological inference using Gaussian random fields

(2008) J CHUMBLEY et al.   NEUROIMAGE